Eli Lilly (LLY) — Entry Risk Score

Stock · re-scored every trading day · data as of 2026-11-12

67
on a 30–98 scale
HOLD
$1,427last close
-11score vs prior day
55–98range since 06-29
+16.0%price since 06-29

The entry score measures one thing: how far Eli Lilly's price sits from a defensible technical level, on a 30–98 scale. High scores (79+) mean the price has pulled back into a zone where risk can be defined; low scores mean the price is extended above its own trend — not that the stock is bad, but that chasing it here carries undefined risk. The full formula is public on our methodology page.

On 2026-11-12, Eli Lilly's price sits 1.70 ATR above its 20-day average ($1,347); it trades above its 200-day average ($1,107); its 14-day RSI is 70; it has moved +13.54% over 20 sessions; our regime filter classifies it as a strong uptrend.

Is Eli Lilly (LLY) a buy right now?

Eli Lilly scores 67/98 (Hold) as of 2026-11-12; it is 0.7% below its 52-week high of $1,437; it is above its 200-day average; it moved +5.41% over the last 5 sessions. A mid-range score means the price is near its recent average: not a stretched entry, not a discount. Not investment advice.

Score history

80 60

Every point is a recorded daily snapshot, committed publicly the evening it was scored — history can't be rewritten after the fact.

DateScoreΔClose
2026-11-1267-11$1,427
2026-11-0678+6$1,354
2026-11-0572+17$1,365
2026-11-0455+0$1,418
2026-11-0355+0$1,409
2026-11-0255+0$1,411
2026-10-2955-14$1,374
2026-10-2869+0$1,288
2026-10-2769+1$1,282
2026-10-2668-1$1,279
2026-10-2369+14$1,273
2026-10-2255-8$1,307

Congress trades in LLY

STOCK Act disclosures by members of Congress, cross-referenced from our Smart Money tracker.

TradedPoliticianTypeAmountReturn since
2026-09-04Rohit Khanna (D)BUY$1,001 - $15,000+17.8%
2025-11-21John Boozman (R)SALE$1,001 - $15,000+27.8%

Our analysis mentioning Eli Lilly

Related stocks

See today's full rankings + entry plan for LLY →

Get the Sunday Brief

One email a week, before the open: what the board did, which calls worked, which didn't, and what changed. Free. No spam, unsubscribe anytime.